We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Amoéba Biocontrol Products Selected for Evaluation on European Vineyards

Amoéba Biocontrol Products Selected for Evaluation on European Vineyards content piece image
Credit: Dino Reichmuth via Unsplash
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Amoéba, producer of a biological biocide capable of eliminating the risk in water and human wounds, and of a biocontrol product for plant protection, still in the testing phase, has announced the signature of a Material Transfer Agreement (MTA) with Certis Europe. This new partnership, with a European specialist in crop protection thanks to its innovative biorational solutions, aims to extend the performance evaluation of Amoéba's biocontrol products for vines in three European countries. 

Amoeba's provision of its amoeba lysate 

The purpose of the research partnership is the delivery by Amoéba of experimental biocontrol products for crop protection. The amoeba lysate Willaertia magna C2c Maky, an alternative solution to "all chemical", has already been tested in 4 European countries through 13 rigorous test protocols. Thus, Amoéba offers to Certis Europe the possibility to access to its patented technology, result of more than 10 years of research and scientific know-how, through new formulations. 

Tests carried out by CERTIS EUROPE in 3 European countries with significant vineyards

In return, CERTIS EUROPE will carry out its own trials in 3 European wine producing countries: 

  1. in Italy (1st wine producer in the world) and in Germany (8th wine producer in the world) for field tests, 
  2. in France for laboratory tests, including rain resistance tests (carried out on potted vine plants in climatic chamber), in order to evaluate the performance of these products in preventing downy mildew diseases on the vine that cause significant yield losses each year. 

The development of a real trials network on different grape varieties and under varied conditions will thus allow the evaluation of various formulations of the Active Substance (amoeba lysate Willaertia magna C2c Maky).

Amoeba and Certis Europe are thus embarking on a targeted research phase which could favor the commercial development of Amoeba's biocontrol solutions if it proves to be conclusive.